Send to

Choose Destination
See comment in PubMed Commons below
Neurology. 2000 Aug 8;55(3):448-50.

Retrospective analysis of the use of cyclosporine in myasthenia gravis.

Author information

  • 1Department of Medicine, Division of Neurology, Duke University Medical Center, Durham, NC 27710, USA.


The authors reviewed the records of patients with myasthenia gravis who took cyclosporine for at least 6 months between November 1987 and January 1999. Of 57 patients who took cyclosporine for an average of 3.5 years, 55 (96%) had clinical improvement. The median time to best clinical response was 7 months. Corticosteroids were discontinued or decreased in 95% of 38 patients taking them. Major side effects included elevated serum creatinine (28%) and malignancy (11%). Five percent could not afford or tolerate the drug.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Support Center